Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A

Antiviral Research

Volumn 124, Issue , 2015, Pages 83-92

  Rattanaburee, Thidarath ^a   Junking, Mutita ^a   Panya, Aussara ^a   Sawasdee, Nunghathai ^a   Songprakhon, Pucharee ^a   Suttitheptumrong, Aroonroong ^a   Limjindaporn, Thawornchai ^a   Haegeman, Guy ^a   Yenchitsomanus, Pa Thai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chemokine; Compound A; Cytokine; Dengue virus; Ribavirin

Indexed keywords

ANTIINFLAMMATORY AGENT; CHEMOKINE; COMPOUND A; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; RANTES; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 2-(4-ACETOXYPHENYL)-2-CHLORO-N-METHYLETHYLAMINE; ACETIC ACID DERIVATIVE; ANTIVIRUS AGENT; TYRAMINE;

A549 CELL LINE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE VIRUS; DENGUE VIRUS 2; DRUG EFFECT; DRUG POTENTIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTYPE; VIRUS INHIBITION; VIRUS REPLICATION; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; DENGUE; DRUG EFFECTS; GENETICS; PHYSIOLOGY; TUMOR CELL LINE; VERO CELL LINE; VIROLOGY;

ACETATES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; CHEMOKINES; CYTOKINES; DENGUE; DENGUE VIRUS; DRUG SYNERGISM; HUMANS; RIBAVIRIN; TYRAMINE; VERO CELLS; VIRUS REPLICATION;

EID: 84946738449     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.10.005     Document Type: Article

References (52)

1. M. Abdel-Hady, S. Bansal, S.M. Davison, M. Brown, S.A. Tizzard, S. Mulla, E. Barnes, P. Davies, G. Mieli-Vergani, and D.A. Kelly Treatment of chronic viral hepatitis C in children and adolescents: UK experience Arch. Dis. Child. 99 2014 505 510
2. C. Agostini, M. Cassatella, R. Zambello, L. Trentin, S. Gasperini, A. Perin, F. Piazza, M. Siviero, M. Facco, M. Dziejman, M. Chilosi, S. Qin, A.D. Luster, and G. Semenzato Involvement of the IP-10 chemokine in sarcoid granulomatous reactions J. Immunol. 161 1998 6413 6420
3. A.J. Ammit, A.L. Lazaar, C. Irani, G.M. O'Neill, N.D. Gordon, Y. Amrani, R.B. Penn, and R.A. Panettieri Jr. Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists Am. J. Respir. Cell Mol. Biol. 26 2002 465 474
4. S. Bansal, A.K. Singal, B.M. McGuire, and B.S. Anand Impact of all oral anti-hepatitis C virus therapy: a meta-analysis World J. Hepatol. 7 2015 806 813
5. S. Bhatt, P.W. Gething, O.J. Brady, J.P. Messina, A.W. Farlow, C.L. Moyes, J.M. Drake, J.S. Brownstein, A.G. Hoen, O. Sankoh, M.F. Myers, D.B. George, T. Jaenisch, G.R. Wint, C.P. Simmons, T.W. Scott, J.J. Farrar, and S.I. Hay The global distribution and burden of dengue Nature 496 2013 504 507
6. J. Blok Genetic relationships of the dengue virus serotypes J. Gen. Virol. 66 Pt 6 1985 1323 1325
7. J.E. Castro, I. Vado-Solis, C. Perez-Osorio, and T.M. Fredeking Modulation of cytokine and cytokine receptor/antagonist by treatment with doxycycline and tetracycline in patients with dengue fever Clin. Dev. Immunol. 2011 2011 370872
8. J. Chang, W. Schul, T.D. Butters, A. Yip, B. Liu, A. Goh, S.B. Lakshminarayana, D. Alonzi, G. Reinkensmeier, X. Pan, X. Qu, J.M. Weidner, L. Wang, W. Yu, N. Borune, M.A. Kinch, J.E. Rayahin, R. Moriarty, X. Xu, P.Y. Shi, J.T. Guo, and T.M. Block Combination of alpha-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo Antivir. Res. 89 2011 26 34
9. K. De Bosscher, W. Vanden Berghe, I.M. Beck, W. Van Molle, N. Hennuyer, J. Hapgood, C. Libert, B. Staels, A. Louw, and G. Haegeman A fully dissociated compound of plant origin for inflammatory gene repression Proc. Natl. Acad. Sci. U. S. A. 102 2005 15827 15832
10. P. Dewint, V. Gossye, K. De Bosscher, W. Vanden Berghe, K. Van Beneden, D. Deforce, S. Van Calenbergh, U. Muller-Ladner, B. Vander Cruyssen, G. Verbruggen, G. Haegeman, and D. Elewaut A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis J. Immunol. 180 2008 2608 2615
11. M.S. Diamond, M. Zachariah, and E. Harris Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA Virology 304 2002 211 221
12. V. Gossye, D. Elewaut, N. Bougarne, D. Bracke, S. Van Calenbergh, G. Haegeman, and K. De Bosscher Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts Arthritis Rheum. 60 2009 3241 3250
13. S. Green, and A. Rothman Immunopathological mechanisms in dengue and dengue hemorrhagic fever Curr. Opin. Infect. Dis. 19 2006 429 436
14. D.J. Gubler The global emergence/resurgence of arboviral diseases as public health problems Arch. Med. Res. 33 2002 330 342
15. D.J. Gubler Dengue, urbanization and globalization: the unholy trinity of the 21(st) Century Trop. Med. Health 39 2011 3 11
16. A.O. Guilarde, M.D. Turchi, J.B. Siqueira Jr., V.C. Feres, B. Rocha, J.E. Levi, V.A. Souza, L.S. Boas, C.S. Pannuti, and C.M. Martelli Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response J. Infect. Dis. 197 2008 817 824
17. S.B. Halstead Dengue Lancet 370 2007 1644 1652
18. P. Halvorsen, J. Raeder, P.F. White, S.M. Almdahl, K. Nordstrand, K. Saatvedt, and T. Veel The effect of dexamethasone on side effects after coronary revascularization procedures Anesth. Analg. 96 2003 1578 1583 (table of contents)
19. K. Heimdal, H. Hirschberg, H. Slettebo, K. Watne, and O. Nome High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression J. Neurooncol. 12 1992 141 144
20. J. Hernandez-Rodriguez, M. Segarra, C. Vilardell, M. Sanchez, A. Garcia-Martinez, M.J. Esteban, C. Queralt, J.M. Grau, A. Urbano-Marquez, A. Palacin, D. Colomer, and M.C. Cid Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis Rheumatol. Oxf. 43 2004 294 301
21. S. Khunchai, M. Junking, A. Suttitheptumrong, S. Kooptiwut, G. Haegeman, T. Limjindaporn, and P.T. Yenchitsomanus NF-kappaB is required for dengue virus NS5-induced RANTES expression Virus Res. 197 2015 92 100
22. J.L. Kyle, and E. Harris Global spread and persistence of dengue Annu. Rev. Microbiol. 62 2008 71 92
23. H.L. Lee, T.V. Phong, and A. Rohani Effects of ribavirin and hydroxyurea on oral infection of Aedes aegypti (L.) with dengue virus Southeast Asian J. Trop. Med. Public Health 43 2012 1358 1364
24. A. Louw, and P. Swart Salsola tuberculatiformis Botschantzev and an aziridine precursor analog mediate the in vivo increase in free corticosterone and decrease in corticosteroid-binding globulin in female Wistar rats Endocrinology 140 1999 2044 2053
25. A. Louw, P. Swart, S.S. de Kock, and K.J. van der Merwe Mechanism for the stabilization in vivo of the aziridine precursor -(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride by serum proteins Biochem. Pharmacol. 53 1997 189 197
26. G.N. Malavige, L.C. Huang, M. Salimi, L. Gomes, S.D. Jayaratne, and G.S. Ogg Cellular and cytokine correlates of severe dengue infection PLoS One 7 2012 e50387
27. N.E. Murray, M.B. Quam, and A. Wilder-Smith Epidemiology of dengue: past, present and future prospects Clin. Epidemiol. 5 2013 299 309
28. T.H. Nguyen, H.Y. Lei, T.L. Nguyen, Y.S. Lin, K.J. Huang, B.L. Le, C.F. Lin, T.M. Yeh, Q.H. Do, T.Q. Vu, L.C. Chen, J.H. Huang, T.M. Lam, C.C. Liu, and S.B. Halstead Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles J. Infect. Dis. 189 2004 221 232
29. T.F. Povoa, A.M. Alves, C.A. Oliveira, G.J. Nuovo, V.L. Chagas, and M.V. Paes The pathology of severe dengue in multiple organs of human fatal cases: histopathology, ultrastructure and virus replication PLoS One 9 2014 e83386
30. R.F. Qi, L. Zhang, and C.W. Chi Biological characteristics of dengue virus and potential targets for drug design Acta Biochim. Biophys. Sin. Shanghai 40 2008 91 101
31. A. Rathakrishnan, S.M. Wang, Y. Hu, A.M. Khan, S. Ponnampalavanar, L.C. Lum, R. Manikam, and S.D. Sekaran Cytokine expression profile of dengue patients at different phases of illness PLoS One 7 2012 e52215
32. A. Rauch, V. Gossye, D. Bracke, E. Gevaert, P. Jacques, K. Van Beneden, B. Vandooren, M. Rauner, L.C. Hofbauer, G. Haegeman, D. Elewaut, J.P. Tuckermann, and K. De Bosscher An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation FASEB J. 25 2011 1323 1332
33. L.L. Reber, F. Daubeuf, M. Plantinga, L. De Cauwer, S. Gerlo, W. Waelput, S. Van Calenbergh, J. Tavernier, G. Haegeman, B.N. Lambrecht, N. Frossard, and K. De Bosscher A dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a mouse model of asthma J. Immunol. 188 2012 3478 3487
34. S.R. Reis, A.L. Sampaio, M. Henriques, M. Gandini, E.L. Azeredo, and C.F. Kubelka An in vitro model for dengue virus infection that exhibits human monocyte infection, multiple cytokine production and dexamethasone immunomodulation Mem. Inst. Oswaldo Cruz 102 2007 983 990
35. B.N. Restrepo, D.M. Isaza, C.L. Salazar, R. Ramirez, M. Ospina, and L.G. Alvarez Serum levels of interleukin-6, tumor necrosis factor-alpha and interferon-gamma in infants with and without dengue Rev. Soc. Bras. Med. Trop. 41 2008 6 10
36. R.S. Rodrigues, A.L. Brum, M.V. Paes, T.F. Povoa, C.A. Basilio-de-Oliveira, E. Marchiori, D.P. Borghi, G.V. Ramos, and F.A. Bozza Lung in dengue: computed tomography findings PLoS One 9 2014 e96313
37. W. Schul, W. Liu, H.Y. Xu, M. Flamand, and S.G. Vasudevan A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs J. Infect. Dis. 195 2007 665 674
38. D.S. Shepard, L. Coudeville, Y.A. Halasa, B. Zambrano, and G.H. Dayan Economic impact of dengue illness in the Americas Am. J. Trop. Med. Hyg. 84 2011 200 207
39. C.P. Simmons, J.J. Farrar, V.V. Nguyen, and B. Wills Dengue N. Engl. J. Med. 366 2012 1423 1432
40. C. Suharti, E.C. van Gorp, W.M. Dolmans, T.E. Setiati, C.E. Hack, R. Djokomoeljanto, and J.W. van der Meer Cytokine patterns during dengue shock syndrome Eur. Cytokine Netw. 14 2003 172 177
41. J.B. Sundstrom, L.K. McMullan, C.F. Spiropoulou, W.C. Hooper, A.A. Ansari, C.J. Peters, and P.E. Rollin Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells J. Virol. 75 2001 6070 6085
42. A. Suttitheptumrong, S. Khunchai, J. Panaampon, U. Yasamut, A. Morchang, C. Puttikhunt, S. Noisakran, G. Haegeman, P.T. Yenchitsomanus, and T. Limjindaporn Compound A, a dissociated glucocorticoid receptor modulator, reduces dengue virus-induced cytokine secretion and dengue virus production Biochem. Biophys. Res. Commun. 436 2013 283 288
43. R. Takhampunya, S. Ubol, H.S. Houng, C.E. Cameron, and R. Padmanabhan Inhibition of dengue virus replication by mycophenolic acid and ribavirin J. Gen. Virol. 87 2006 1947 1952
44. V. Tricou, N.N. Minh, J. Farrar, H.T. Tran, and C.P. Simmons Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue PLoS Negl. Trop. Dis. 5 2011 e1309
45. J. Vardy, K.S. Chiew, J. Galica, G.R. Pond, and I.F. Tannock Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy Br. J. Cancer 94 2006 1011 1015
46. D.W. Vaughn, S. Green, S. Kalayanarooj, B.L. Innis, S. Nimmannitya, S. Suntayakorn, T.P. Endy, B. Raengsakulrach, A.L. Rothman, F.A. Ennis, and A. Nisalak Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity J. Infect. Dis. 181 2000 2 9
47. D.W. Vaughn, S. Green, S. Kalayanarooj, B.L. Innis, S. Nimmannitya, S. Suntayakorn, A.L. Rothman, F.A. Ennis, and A. Nisalak Dengue in the early febrile phase: viremia and antibody responses J. Infect. Dis. 176 1997 322 330
48. M.M. Vennemann, B. Loddenkotter, T. Fracasso, E.A. Mitchell, A.S. Debertin, K.P. Larsch, J.P. Sperhake, B. Brinkmann, C. Sauerland, M. Lindemann, and T. Bajanowski Cytokines and sudden infant death Int. J. Legal Med. 126 2012 279 284
49. J.L. Webb Effect of more than one inhibitor Enzyme and Metabolic Inhibitors 1961 Academic Press New York
50. S. Wust, D. Tischner, M. John, J.P. Tuckermann, C. Menzfeld, U.K. Hanisch, J. van den Brandt, F. Luhder, and H.M. Reichardt Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis PLoS One 4 2009 e8202
51. S. Yeruva, G. Ramadori, and D. Raddatz NF-kappaB-dependent synergistic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines Int. J. Colorectal Dis. 23 2008 305 317
52. B. Yohan, R.I. Kendarsari, K. Mutia, A. Bowolaksono, A.R. Harahap, and R.T. Sasmono Growth characteristics and cytokine/chemokine induction profiles of dengue viruses in various cell lines Acta Virol. 58 2014 20 27